New Animal Drugs for Use in Animal Feeds; Ivermectin and Bacitracin Methylene Disalicylate

Resumen

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Merial Ltd. The NADA provides for use of ivermectin and bacitracin methylene disalicylate (BMD) Type A medicated articles to make Type B and Type C medicated swine feeds for use as antiparasitics, antibacterials, and growth promotants.